| 1 |
35340872 | Rosiglitazone ameliorates acute hepatic injury via activating the Nrf2 signaling pathway and inhibiting activation of the NLRP3 inflammasome. | 2022 Apr |
1 |
| 2 |
28357820 | Preventive effect of rosiglitazone on liver injury in a mouse model of decompression sickness. | 2017 Mar |
1 |
| 3 |
28652653 | Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis. | 2017 Jun 14 |
1 |
| 4 |
24898700 | Tumour necrosis factor-α promotes liver ischaemia-reperfusion injury through the PGC-1α/Mfn2 pathway. | 2014 Sep |
1 |
| 5 |
18991162 | Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice. | 2009 |
1 |
| 6 |
18846339 | Significance of rosiglitazone inhibiting TLR4 expression in partial hepatic ischemia/reperfusion of mice. | 2008 Oct |
1 |